bevacizumab,atezolizumab
roche
['bevacizumab', 'bcsm', 'hcc', 'atezo']
adjuvant atezolizumab/bevacizumab shows recurrence-free survival benefit over active surveillance in hcc #aacr #hcc #hpbcsm #oncology #nursing #aacr23 
Capturing the voice of nursing professionals in the oncology news landscape.